Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1973)	9/30/2000 12:03:35 AM
From: JFitnich	Read Replies (1) \| Respond to of 4974

Another sign of the times... Registering...not sold yet. However, this is a huge chunk of money for a company like Corvas that has survived year to year on small private placements. Friday September 29, 5:50 pm Eastern Time Press Release SOURCE: Corvas International, Inc. Corvas International Files Registration Statement For Common Stock Offering SAN DIEGO, Sept. 29 /PRNewswire/ -- Corvas International, Inc. (Nasdaq: CVAS - news)today announced that it has filed a registration statement with the Securities and Exchange Commission for the sale of 5,000,000 shares of Corvas common stock in a proposed public offering. The Company will also grant the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any. CIBC World Markets Corp. is acting as lead manager for the offering. Prudential Vector Healthcare Group, a unit of Prudential Securities, and U.S. Bancorp Piper Jaffray are acting as co-managers. (snip)